Applied Therapeutics (APLT)
(Delayed Data from NSDQ)
$7.87 USD
-0.53 (-6.26%)
Updated Oct 3, 2024 04:00 PM ET
Pre-Market: $7.69 -0.18 (-2.23%) 8:14 AM ET
2-Buy of 5 2
F Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.13 |
EPS Last Quarter | -0.13 |
Last EPS Surprise | -30.00% |
ABR | 1.17 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.84 |
Next Year | -0.36 |
EPS (TTM) | -1.09 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 0.30M | 50.75M |
# of Estimates | NA | NA | 2 | 2 |
High Estimate | NA | NA | 0.30M | 67.00M |
Low Estimate | NA | NA | 0.30M | 34.50M |
Year ago Sales | 0.00M | -0.67M | 9.99M | 0.30M |
Year over Year Growth Est. | NA | NA | -97.00% | 16,816.67% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.13 | -0.13 | -0.84 | -0.36 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.11 | -0.11 | -0.80 | -0.36 |
High Estimate | -0.11 | -0.11 | -0.80 | -0.35 |
Low Estimate | -0.14 | -0.14 | -0.88 | -0.36 |
Year ago EPS | -0.47 | -0.33 | -1.42 | -0.84 |
Year over Year Growth Est. | 72.34% | 60.61% | 40.85% | 57.74% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 2 | 2 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.13 | -0.13 | -0.84 | -0.36 |
7 Days Ago | -0.13 | -0.13 | -0.84 | -0.36 |
30 Days Ago | -0.13 | -0.13 | -0.84 | -0.36 |
60 Days Ago | -0.15 | -0.15 | -1.06 | -0.38 |
90 Days Ago | -0.17 | -0.17 | -1.10 | -0.36 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.13 | -0.13 | -0.84 | -0.36 |
Zacks Consensus Estimate | -0.13 | -0.13 | -0.84 | -0.36 |
Earnings ESP | 0.00% | 0.00% | 0.00% | -1.41% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.13 | -0.16 | -0.33 | -0.47 | NA |
Estimate | -0.10 | -0.07 | -0.15 | NA | NA |
Difference | -0.03 | -0.09 | -0.18 | NA | -0.10 |
Surprise | -30.00% | -128.57% | -120.00% | NA | -92.86% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more